COMMUNIQUÉS West-GlobeNewswire

-
Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
24/09/2024 -
Conception Nurseries Launches TrueClones™ X
24/09/2024 -
Tersa Earth and Silica-X Sign MoU to Revolutionize Mining and Waste Management with AI-Powered Biotech and Zero-Waste Solutions
24/09/2024 -
Curium Announces the Official Opening its New Netherlands Facility for the Production of Lutetium-177 – a Game Changer Therapy Isotope for Cancer Patients Worldwide
24/09/2024 -
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology – Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference
24/09/2024 -
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
24/09/2024 -
CytoDyn Announces Preliminary Findings in Study with SMC Laboratories
24/09/2024 -
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
24/09/2024 -
Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis
24/09/2024 -
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
24/09/2024 -
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
24/09/2024 -
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner
24/09/2024 -
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
24/09/2024 -
FDA Accepts Arcutis’ Supplemental New Drug Application for ZORYVE® (roflumilast) Foam for the Treatment of Scalp and Body Psoriasis in Adults and Adolescents Ages 12 and Over
24/09/2024 -
Starton Therapeutics’ Chief Executive Officer Chosen as 2024 Honoree by the Icla da Silva Foundation
24/09/2024 -
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
24/09/2024 -
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
24/09/2024 -
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
24/09/2024 -
Certara’s Simcyp Consortium Celebrates 25th Anniversary
24/09/2024
Pages